Atreca could gain 100% with positive data for cancer drug: Jefferies
- Atreca (NASDAQ:BCEL) shares gained ~7%
intraday after Jefferies reaffirmed its positive view on the company. However, the stock retraced gains to close marginally higher. - The analyst Chris Howerton said that Atreca could gain as much as 100% if the lead…
